KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

National Health Investors (NHI) Gains from Investment Securities (2016 - 2025)

National Health Investors (NHI) has disclosed Gains from Investment Securities for 17 consecutive years, with $434000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Gains from Investment Securities changed N/A year-over-year to $434000.0, compared with a TTM value of $456000.0 through Dec 2025, down 92.16%, and an annual FY2025 reading of $456000.0, down 92.16% over the prior year.
  • Gains from Investment Securities was $434000.0 for Q4 2025 at National Health Investors, up from -$633000.0 in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $5.4 million in Q3 2024 and bottomed at -$1.2 million in Q3 2021.
  • Average Gains from Investment Securities over 5 years is $418333.3, with a median of $128000.0 recorded in 2025.
  • Peak annual rise in Gains from Investment Securities hit 5271.43% in 2023, while the deepest fall reached 5471.43% in 2023.
  • Year by year, Gains from Investment Securities stood at -$1.2 million in 2021, then soared by 75.02% to -$288000.0 in 2022, then plummeted by 30.56% to -$376000.0 in 2023, then surged by 1541.22% to $5.4 million in 2024, then tumbled by 91.99% to $434000.0 in 2025.
  • Business Quant data shows Gains from Investment Securities for NHI at $434000.0 in Q4 2025, -$633000.0 in Q3 2025, and $527000.0 in Q2 2025.